Female Sexual Arousal Disorder - Treating Common Sexual Problems: Womens Sexual Health


Content provided by the Faculty of the Harvard Medical School
small text medium text large text

Female sexual arousal disorder


When a woman becomes aroused through thoughts and fantasies, physical stimulation, or both, blood flows to her pelvic region, causing her genital tissues to swell and her vagina to moisten (see "The phases of sexual response"). These changes indicate her physical readiness for sexual intercourse. With female sexual arousal disorder, however, the sequence breaks down, and the woman's body doesn't produce the necessary response.

Because for years this problem was considered evidence of either a psychological issue or a hormone imbalance, treatment was either counseling or estrogen therapy. Then medical researchers examined another possibility. Since blood flow plays a crucial role in arousal, researchers speculated that blood flow problems might produce arousal disorders in women, much the same way that diminished blood flow can cause erectile dysfunction in men. The search for a female Viagra was on.

However, researchers soon learned that arousal is more complex in women than in men. Pfizer, the maker of Viagra, tested the drug in women and found that it did alter blood flow to the genitals, but it did not improve libido in most women. Still, researchers are looking at other drugs and products aimed at increasing genital blood flow in the hopes that these will be effective treatments for female arousal problems.

Making a diagnosis

Your doctor will first want to hear your account of any problems you have becoming aroused and achieving and maintaining vaginal lubrication in response to sexual excitement. To find an effective treatment, your doctor must determine the possible causes. He or she will try to identify the influencing factors by asking you detailed questions about your general physical and emotional health, the stresses in your life, your relationship with your partner, your expectations about sex based on your upbringing, the amount of foreplay and direct stimulation you receive during lovemaking, the medications you're taking, and whether you've gone through menopause. It's likely that your doctor will also perform tests to check for blood flow issues or hormone imbalances, as these are principal sources of arousal disorders.

Treating vaginal dryness

Vaginal dryness is a common cause of female sexual arousal disorder. Decreased lubrication or lack of lubrication and loss of elasticity can make intercourse uncomfortable. These changes can be approached from two directions: using lubricants to treat the symptom of dryness, or using hormones to treat the cause of the problem.

Using artificial lubrication to ease vaginal discomfort is straightforward. A certain amount of vaginal elasticity will return naturally once adequate lubrication allows a woman to engage in regular intercourse. By contrast, hormone treatments — either topical or systemic — are designed to address the problem at its source. Decreased estrogen levels diminish vaginal secretions; thus, replacing estrogen after menopause can increase lubrication. Hormone therapy for menopausal symptoms, including vaginal dryness, is available in many different combinations and preparations, such as pills, patches, and vaginal creams. Vaginal hormone treatments — in which estrogen is applied directly to vaginal tissues — are often quite effective in reversing age-related thinning and dryness.

When weighing the right approach for treating vaginal dryness, carefully consider the severity of your symptoms, your medical history and health risks, and any other menopausal symptoms you may be having. The following information may help guide your choice.

Lubricants

If vaginal dryness is your primary or only concern, a lubricating liquid or gel that temporarily alleviates vaginal discomfort may be your best solution. The following products are available over the counter.

Astroglide. This is a clear, thin, odorless liquid with a slippery feel that closely approximates natural vaginal secretions. You can apply it to the vaginal opening or to the penis before intercourse. Astroglide is nonstaining and has a neutral pH, so it won't irritate the vagina or promote vaginal infections.

K-Y Silk-E. This gel was developed by the makers of K-Y Jelly especially for vaginal lubrication. Because it was formulated to mimic a woman's natural vaginal moisture, it's a better alternative than K-Y Jelly for treating vaginal dryness.

Replens. This lotion-like vaginal moisturizer clings to the vaginal lining, simulating natural secretions. Each application lasts 48 to 72 hours. Replens is a good option if your dryness is bothersome even when you're not engaged in sexual activity. Although it may make intercourse more comfortable, Replens is not a substitute for vaginal lubricants such as Astroglide or Silk-E. This lotion does, however, have the added benefit of making your vaginal environment more acidic, which helps ward off infections. Gyne-Moistrin is a similar product.

Hormone therapy

For perimenopausal and postmenopausal women, reintroducing estrogen into the vaginal tissues can reverse vaginal dryness, thinning, shortening, and other age-related changes, as opposed to the temporary relief of dryness offered by a lubricant. Estrogen can also ease other symptoms of menopause, such as hot flashes, night sweats, palpitations, headaches, and insomnia, but it carries some risks as well. Some studies have found that women taking certain hormone products, particularly those in which estrogen is taken orally, have a higher risk of heart attack, stroke, blood clots, and breast cancer. However, these studies have their critics, who point out that since only a few specific hormone preparations have been examined, it's unclear whether other hormone products carry the same risks (see "Postmenopausal hormone therapy: Your questions answered").

Postmenopausal hormone therapy: Your questions answered

In the wake of the Women's Health Initiative (WHI) trial, many women tossed out their hormone pills for fear that hormone therapy would raise their risk of cardiovascular problems and other ills. But some medical experts cautioned that the study had flaws. One such expert, Dr. Alan Altman, a medical editor of this report, believes that hormone therapy was painted with too broad a brush, and some data support that view.

The WHI tested the hormone pills Prempro (an estrogen plus progestin pill) and Premarin (estrogen alone) for preventing heart disease, osteoporosis, and other common health problems. The trial of Prempro was stopped early, in 2002, because the women taking this medication had a higher risk of breast cancer, heart disease, stroke, and blood clots. The hormone combination showed some benefit — such as reductions in colorectal cancer and hip and spinal fractures — but this wasn't enough to outweigh the risks. The Premarin trial also ended early after researchers found that the risk of stroke increased by 40% in women using this drug. Interestingly, though, they also found that there were fewer cases of breast cancer in the women taking estrogen alone than in the women taking a placebo, and that there was a 50% reduction in heart attack risk in women who started the estrogen therapy in their 50s.

Other studies on different kinds of hormonal therapy have been published and more are on the way, but many women are still struggling to make sense of the data and the diversity of opinions on hormone therapy. Here, Dr. Altman, an assistant clinical professor of obstetrics, gynecology, and reproductive biology at Harvard Medical School, answers some questions about hormone therapy.

Q. Let's start with the WHI, since it changed the public perception of hormone therapy. What did we learn from this study?

A. What people were told was that the WHI showed that "hormones were bad for women." As a result of this, the FDA recommended using hormone therapy only for severe menopausal symptoms — in the lowest effective dose and for the shortest possible time.

But the problem was that the WHI study wasn't about all hormones, and it wasn't about all women — it was a study of Premarin and Prempro, two hormone products that are completely different from the other 40-plus hormones available in the United States. And it's a study of women who were, on average, 12-plus years beyond their final menstrual period.

Q. Why is the fact that Prempro and Premarin were used in the study important here?

A. Prempro is a product that combines horse-derived estrogen and a very potent progestin, called MPA, in one pill. Many of us who specialize in postmenopausal care have been aware for years that MPA is too strong and can act to reduce the benefits that estrogens may provide. There are many other newer and safer progestins, both natural and synthetic, that are available. In fact, I don't recommend using Prempro.

Both products are also oral estrogens. And there are big differences between oral and non-oral products. When estrogen is taken as a pill, it's first processed through the liver. This stimulates proteins associated with heart disease and stroke, such as C-reactive protein, activated protein C, and clotting factors. But non-oral estrogen isn't first processed by the liver and — at the same level of blood concentration — doesn't have these effects.

The bottom line is that there are far better and safer combinations of hormone therapy out there, especially non-oral estrogen products like patches, gels, creams, rings, and tablets. These are all plant-based and bioidentical to the naturally occurring hormones. [Bioidentical hormones are identical in molecular structure to the hormones women make in their bodies. They're not found in this form in nature but are made, or synthesized, from a plant chemical extracted from yams and soy.]

Q. Does that mean a different estrogen or combined estrogen-progestin might have fewer side effects? And a different mode of delivery, such as a transdermal (skin) patch or skin cream, might be safer?

A. Exactly. Different forms of hormones are recognized differently by cells, so it makes sense that their effects might also be different. For example, one study of women taking estrogen alone found that those who took conjugated equine estrogens (Premarin) had a 78% higher risk for blood clots than users of esterified estrogen (Menest). In another study, women who took an oral estrogen increased their risk of blood clots by four times that of those who used an estrogen patch, which didn't increase the risk of blood clots at all. Also, the progestin medroxyprogesterone acetate (Provera) interferes with estrogen's good effects on cholesterol more than micronized progesterone (Prometrium) does.

Q. One of your criticisms of the WHI has to do with the age of the women involved in the study. Why is age a factor?

A. It's not their age per se. It's about how long after menopause the hormone therapy begins. In the WHI, only 17% of the women started the hormones within five years of their final menstrual period. Years of studies and experience in using hormones have demonstrated that estrogen is a preserver of good function. It isn't a repairer of bad function, except in the case of vaginal dryness. So if you are to get the benefits of estrogen, it is essential to start at the appropriate time. It makes sense to continue hormones following directly from the time when you had these hormones in your body, not to reintroduce them 10 years later.

Most of the women in the WHI were in their 60s and 70s. Prevention needs to start earlier than that.

Q. Is there evidence that women who start on hormones soon after menopause have better outcomes?

A. By examining the WHI data, we found that the younger women who began taking hormones within five years of their final menstrual period cut their risk of heart disease in half.

Other studies support this. In early 2006, researchers at Harvard Medical School analyzed data from the Nurses' Health Study and found that the women who started hormone therapy within about four years of menopause had a 30% lower risk of heart disease than the women who never used hormones. On the other hand, starting on hormones 10 years after menopause or after age 60 showed little if any benefit.

What this shows is that the "when" part of the equation is important. The message shouldn't be "Don't take hormones." It should be "What can you take — and when."

Q. These studies focus on heart health. What about breast cancer risk? Didn't the WHI demonstrate that hormones can raise the risk of breast cancer?

A. WHI did find that the women taking Prempro were at higher risk for breast cancer. But in the estrogen-alone (Premarin) part of the study, the women taking estrogen had fewer cases of breast cancer (a rate of 28 per 10,000) than the women taking a placebo (34 per 10,000). The experts conducting the study reported that the difference in these rates may not be statistically significant. So there is conflicting information, and medical experts can't explain the reason for this yet. But again, different hormone products and different delivery systems have different risks and benefits.

Q. Other studies are being conducted to help answer questions about hormones. In the meantime, what's your advice to women considering hormone therapy?

A. Remember that each medical study that you read about is only one piece of a puzzle. Only the completed puzzle can reveal the final answer, and we don't have a completed puzzle here. So you need to carefully weigh your decision based on all the information available, not just one study.

Estrogen comes in several forms with a range of doses and formulations. The benefits, risks, and side effects vary depending on the form of hormone replacement therapy used. Estrogen applied directly to the vaginal area (through a cream, gel, tablet, or ring) has fewer effects on the rest of the body because the hormone doesn't enter the bloodstream to the same degree as it does with pills or patches.

The following provides a brief overview of the different kinds of hormone preparations. Some doctors also prescribe Estratest, a pill that combines estrogen and testosterone, to treat menopausal symptoms and desire or arousal problems (see "Testosterone for women").

Estrogen and progestogen pills. These medications contain one or both hormones. They are quite effective in treating vaginal changes. Because these medications enter the bloodstream and have systemic effects, they also reverse bone loss and relieve hot flashes, insomnia, and other symptoms of menopause. Estrogen alone (called unopposed estrogen) is recommended only for women who have had a hysterectomy because taking the hormone by itself can raise the risk of developing uterine cancer. Adding a progestogen (a version of the hormone progesterone) to the formula protects against this risk.

Hormone patches. Applied like a Band-Aid, patches deliver a continuous dose of estrogen for up to a week. Patches are worn on the abdomen or buttocks and are replaced every three to seven days. Typically, an oral progestogen is used along with the patch, although some patches contain both estrogen and progestogen. Because this method delivers hormones systemically, it has some of the same benefits and drawbacks as hormone pills. But since the estrogen enters the bloodstream without passing through the liver, it may be a more natural way to take estrogen. It may not improve cholesterol levels to the same extent as products taken orally, but it avoids blood clotting and gallbladder problems seen with the pills. Some users report that the patch can itch or fall off.

Vaginal estrogen creams. In this therapy, a dose of cream is inserted into the vagina with an applicator two to seven days a week. Only small doses are needed to relieve vaginal dryness. Creams treat vaginal changes directly, so typically they don't address other menopausal symptoms, such as hot flashes. Initially, most of the estrogen is taken up in the vaginal tissue. However, as the vaginal lining is replenished, more of it is absorbed into the bloodstream. The use of vaginal estrogen cream has given way to more controlled delivery methods, such as an estrogen ring or patch. Estrogen cream should not be used as a lubricant before intercourse because it can be absorbed through a partner's skin.

Transdermal gels and creams. In these therapies, hormones are applied to the skin and work systemically to treat all menopausal symptoms. One product, EstroGel, comes in a clear, odorless, alcohol-based gel that's delivered from a metered-dose pump. The gel is applied once a day on one arm from the wrist to the shoulder. The gel dries completely in two to five minutes. Another product, Estrasorb, is a cream that comes in individual foil packets and is rubbed into the thighs and buttocks.

Estrogen rings. For this therapy, you insert a ring into the vagina in much the same way that you insert a diaphragm. The ring releases estrogen gradually and needs replacement about every three months. Two types of rings are currently available: one that offers local effects and one that is systemic. Estring releases a low dose of estrogen that is not absorbed into other areas of the body — which means you avoid the effects associated with hormone pills and patches, but you won't get relief from hot flashes and other menopausal symptoms. Femring contains higher doses of estrogen and offers systemic effects, so it treats hot flashes and other menopausal systems in addition to vaginal dryness. Although both rings can be removed temporarily and reinserted, neither type has to be removed before sexual intercourse.

Vaginal estrogen tablets. An estrogen tablet, sold as Vagifem, inserted into the vagina with an applicator twice a week, can relieve dryness and irritation. This form of medication treats only vaginal symptoms. Since very little estrogen is absorbed into the body, the tablet doesn't carry the risks of systemic medications and won't relieve other symptoms of menopause.

Testosterone cream. If vulvar atrophy is advanced, your genital tissue may respond to a low-dose testosterone cream. The cream is rubbed directly into the vulva three nights a week. Because the FDA has not approved testosterone creams for use in women, they are available only through compounding pharmacies, which assemble ingredients to make medications prescribed by doctors.

Increasing genital blood flow

Speculation that women's arousal difficulties may be related to insufficient blood flow opened another possible avenue of treatment for female sexual arousal disorder. But efforts to find a female Viagra haven't panned out thus far. The drug company Pfizer had long hoped to prove that Viagra improved sexual function in women. But after eight years of testing failed to yield the desired results, Pfizer announced in 2004 that it would no longer test Viagra on women. Interestingly, studies found that the drug increased genital blood flow, but for most women that didn't translate into a greater desire to have sex. Still, other researchers and companies are studying and selling products aimed at increasing genital blood flow in women. Here's a closer look at a few of them.

Topical medications. Researchers are studying several creams and gels that deliver medication to widen blood vessels. These products are rubbed into the genital tissues before intercourse to enhance arousal. One such gel, made with prostaglandin E-1, is undergoing clinical trials under the brand name Femprox. Prostaglandin E-1, a naturally occurring substance, is the active ingredient in the drug alprostadil, which is used for penile injection therapy. A small 2005 study conducted by the maker of the cream found that the cream was helpful, but more study is needed. Researchers are also investigating the effectiveness of a vaginal suppository that delivers phentolamine, another medication used in penile injection therapy. Additionally, the over-the-counter supplement Zestra claims to enhance sexual function in part by increasing genital blood flow (see "Alternative therapies for sexual problems").

Mechanical devices. A small pumplike device — consisting of a small plastic cup that fits over the clitoris and surrounding tissue — uses suction to draw blood into the clitoris, causing it to swell. This FDA-approved unit is sold by prescription to women with arousal disorders under the brand name Eros-CTD (clitoral therapy device).

Sex therapy techniques

If your doctor feels your problem has emotional roots, he or she will recommend sex therapy as the first step in treatment. The sex therapist's role is to help you identify the thoughts, feelings, and behaviors that might be interfering with your sexual enjoyment. He or she will also help you become more in touch with your erotic feelings and grow more comfortable with your sexuality. In addition to sensate focus exercises, the therapist will encourage you to try a range of techniques, such as sexual fantasy training, masturbation exercises, and the use of erotica and vibrators. Because many women find that being able to share their feelings with their partner is a prerequisite for arousal, therapy will also concentrate on improving communication and enhancing feelings of intimacy between you and your partner.

   Treating common sexual problems: 4 of 6   


Harvard Logo
Last updated: January 23, 2007

This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, Use of Content Agreement and AOL Body Advertising Policy. Read more about our content partners.

Search


Where Does it Hurt?

body symptoms

If you're experiencing aches and pains we can help you find answers. Find out what your symptoms mean for your health.